Table 3 Implementation status of routine ophthalmological screening.

From: A real-world descriptive study of screening practices for hydroxychloroquine retinopathy in Japan using an insurance claims database

 

Initiation

1 year

2 years

3 years

4 years

5 years

Patients

2567

1680

1159

773

474

256

All of six examinations*

31.4%

21.8%

26.7%

27.6%

28.3%

29.7%

Visual acuity test

82.0%

70.2%

73.9%

75.0%

75.7%

75.4%

Intraocular pressure test

85.6%

73.4%

77.3%

77.5%

75.7%

76.6%

Slit-lamp microscopy

86.0%

75.0%

79.3%

78.7%

77.2%

78.1%

SD-OCT

70.4%

58.7%

63.3%

64.6%

64.6%

67.6%

VF

56.5%

44.3%

53.0%

54.1%

53.8%

55.1%

Color vision test

43.1%

28.4%

33.7%

34.4%

33.8%

36.3%

FAF

10.3%

9.5%

10.4%

10.3%

10.1%

11.7%

mfERG

0.5%

0.2%

0.2%

0.1%

0.0%

0.0%

SD-OCT and VF

50.6%

39.3%

47.9%

49.4%

49.4%

52.0%

SD-OCT or VF

76.3%

63.7%

68.4%

69.2%

69.0%

70.7%

  1. SD-OCT spectral-domain optical coherence tomography, VF automated visual field test, FAF fundus autofluorescence, mfERG multifocal electroretinogram.
  2. *The six screening examinations included visual acuity, intraocular pressure test, slit-lamp microscopy, SD-OCT, VF, and color vision tests.